BiotechTube
Home/SweetBio/Kayla Rodriguez Graff, MBA
KR

Kayla Rodriguez Graff, MBA

Co-founder, Chief Executive Officer

SweetBio

Therapeutic Areas

Wound CareDermatology

SweetBio Pipeline

DrugIndicationPhase
VERISDaily wound care (e.g., clinic wounds)Approved
APISChronic and acute wounds (CTP/skin substitute)Approved

Leadership Team at SweetBio

IR
Isaac Rodriguez, PhD
Co-founder, Chief Science Officer
View full SweetBio profile